Beauty Health director awarded 57,692 Class A RSUs in Form 4

Rhea-AI Filing Summary

The Beauty Health Company (SKIN) reported an equity award to one of its directors. On 11/13/2025, the director received 57,692 restricted stock units (RSUs) of Class A common stock. Each RSU represents a contingent right to receive one share, subject to time-based vesting conditions. The RSUs vest on the earlier of the one-year anniversary of the grant date and the date of the Company’s 2026 Annual Meeting of Stockholders, as long as the director continues to serve on the board through that time. Following this grant, the director beneficially owns 57,692 Class A shares directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider SCHAISON PHILIPPE

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	57,692	$0.00	--

Holdings After Transaction: Class A Common Stock — 57,692 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SCHAISON PHILIPPE

(Last) (First) (Middle)

C/O THE BEAUTY HEALTH COMPANY

2165 SPRING STREET

(Street)

LONG BEACH CA 90806

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Beauty Health Co [ SKIN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	11/13/2025		A(1)		57,692	A(1)	(1)	57,692	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock of The Beauty Health Company (the "Company"). The RSUs are subject to time-vesting conditions. The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2026 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time.

Remarks:

	/s/ Paul Bokota, Attorney-in-Fact for Philippe Schaison	11/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did The Beauty Health Company (SKIN) report?

The company reported a grant of 57,692 restricted stock units (RSUs) of Class A common stock to one of its directors on 11/13/2025.

Who received the RSU grant reported by The Beauty Health Company (SKIN)?

A director of The Beauty Health Company received the RSU grant, as indicated by the relationship box checked for Director on the form.

What are the vesting terms of the 57,692 RSUs granted by SKIN?

The 57,692 RSUs vest on the earlier of the one-year anniversary of the 11/13/2025 grant date and the date of the 2026 Annual Meeting of Stockholders, contingent on continued board service.

How many SKIN shares does the director beneficially own after this transaction?

After the reported transaction, the director beneficially owns 57,692 shares of The Beauty Health Company’s Class A common stock, held directly.

What does each RSU granted by The Beauty Health Company represent?

Each RSU represents a contingent right to receive one share of The Beauty Health Company’s Class A common stock, subject to the stated vesting conditions.

Was the Form 4 for SKIN filed for one or multiple reporting persons?

The Form 4 was filed by one reporting person, as indicated by the checkbox selection on the form.